# Safety Profile of the Combination of Levosimendan and IV Beta Blocker in Cardiogenic Shock: a Retrospective Study

> **NCT04938375** · — · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 25 (estimated)

## Conditions studied

- Cardiogenic Shock
- Arrythmia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04938375
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-07-30
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2021-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04938375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04938375, "Safety Profile of the Combination of Levosimendan and IV Beta Blocker in Cardiogenic Shock: a Retrospective Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04938375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*